Preparation and characterization of Furosemide-Eudragit controlled release systems

被引:37
作者
Aceves, JM [1 ]
Cruz, R [1 ]
Hernandez, E [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Estudios Super, Cuautitlan 54740, Estado Mexico, Mexico
关键词
Furosemide solid dispersions; infrared spectroscopy; X-ray diffraction patterns; crystals; dissolution rate; Eudragit;
D O I
10.1016/S0378-5173(99)00303-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid dispersions and physical mixtures were prepared and characterized by X-ray diffraction, infrared spectroscopy, electronic microscopy and dissolution rate studies. The characterization with X-ray diffraction showed a transition from the crystalline to the amorphous phase. A new phase near 50% Furosemide concentration with both types of carriers was present. From infrared spectroscopy strong interactions between amine and carbonyl groups from both the Furosemide and the polymers were found. Electronic microscopy analysis showed that the Furosemide changed its crystalline habit from needle to a new spherical phase, with diameter near to 1 mu m. Solid dispersions were prepared in order to modify the system characteristics. The Furosemide dissolution rate was determined in order to follow the behavioural changes of the system. Scanning electron microscopy showed the presence of micro spheres within the polymeric matrix, and the channels formed due to the Furosemide dissolution inside the Eudragit: this fact modified the release pattern of the Furosemide system. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 13 条
[1]  
ANSEL HC, 1990, PHARM DOSAGE FORMS D, P1
[2]   POLYMORPHIC DIFFERENCES IN ALPHA-FORM AND BETA-FORM CRYSTALS OF 2R, 4S, 6-FLUORO-2-METHYL-SPIRO[CHROMAN-4,4'-IMIDAZOLINE]-2',5-DIONE (M79175) AS DETERMINED BY X-RAY-DIFFRACTION, INFRARED-SPECTROSCOPY, AND DIFFERENTIAL SCANNING CALORIMETRY [J].
ASHIZAWA, K ;
UCHIKAWA, K ;
HATTORI, T ;
SATO, T ;
MIYAKE, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (07) :635-637
[3]  
BLOCH DW, 1971, J PHARM SCI, V60, P1281
[4]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[5]   ACCELERATED STABILITY OF AN X-RAY AMORPHOUS FRUSEMIDE-POLYVINYLPYRROLIDONE SOLID DISPERSION [J].
DOHERTY, C ;
YORK, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (12) :1969-1987
[6]  
Hiroshi Y, 1991, CHEM PHARM BULL, V39, P465
[7]  
MAJERSON M, 1966, J PHARM SCI, P1323
[8]   PHYSICOCHEMICAL CHARACTERIZATION OF FUROSEMIDE MODIFICATIONS [J].
MATSUDA, Y ;
TATSUMI, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 60 (01) :11-26
[9]  
Robinson RJ, 1987, CONTROLLED DRUG DELI, P4
[10]  
RUBINSTEIN HM, 1987, PHARM TECHNOLOGY CON, V1, P88